UnitedHealth Group Incorporated $UNH Shares Acquired by RNC Capital Management LLC

RNC Capital Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,685 shares of the healthcare conglomerate's stock after acquiring an additional 3,659 shares during the quarter. RNC Capital Management LLC's holdings in UnitedHealth Group were worth $6,765,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Greatmark Investment Partners Inc. increased its position in shares of UnitedHealth Group by 10.2% during the 2nd quarter. Greatmark Investment Partners Inc. now owns 810 shares of the healthcare conglomerate's stock worth $253,000 after purchasing an additional 75 shares during the last quarter. Caliber Wealth Management LLC KS increased its position in shares of UnitedHealth Group by 43.6% during the 2nd quarter. Caliber Wealth Management LLC KS now owns 10,360 shares of the healthcare conglomerate's stock worth $3,232,000 after purchasing an additional 3,148 shares during the last quarter. BlueChip Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 10.0% during the 2nd quarter. BlueChip Wealth Advisors LLC now owns 891 shares of the healthcare conglomerate's stock worth $278,000 after purchasing an additional 81 shares during the last quarter. Rehmann Capital Advisory Group increased its position in shares of UnitedHealth Group by 50.4% during the 2nd quarter. Rehmann Capital Advisory Group now owns 8,642 shares of the healthcare conglomerate's stock worth $2,696,000 after purchasing an additional 2,897 shares during the last quarter. Finally, Parcion Private Wealth LLC boosted its holdings in UnitedHealth Group by 8.7% during the 2nd quarter. Parcion Private Wealth LLC now owns 1,303 shares of the healthcare conglomerate's stock valued at $406,000 after acquiring an additional 104 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. KeyCorp raised their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a report on Wednesday, October 8th. Cantor Fitzgerald restated an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Barclays lifted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a research note on Thursday, October 9th. Bank of America lifted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the company an "outperform" rating in a research note on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Hold" and a consensus target price of $385.13.

UnitedHealth Group Price Performance

UNH stock opened at $361.29 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business has a 50 day moving average price of $335.48 and a 200 day moving average price of $341.42. The stock has a market cap of $327.21 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 2.36 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.